Yomo, T <br/><br/>
Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation.  [electronic resource] 

 -  Artificial organs  May 2000 
 - 355-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-564X 
<br/><br/><label>Standard No.: </label>10.1046/j.1525-1594.2000.06493.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--antagonists & inhibitors<br/>Adenosine Triphosphate--metabolism<br/>Analysis of Variance<br/>Anti-Bacterial Agents--antagonists & inhibitors<br/>Blood Platelets--drug effects<br/>Cell Degranulation--drug effects<br/>Collagen--antagonists & inhibitors<br/>Heart-Assist Devices<br/>Humans<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Count--drug effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Ristocetin--antagonists & inhibitors<br/>Thromboxane A2--antagonists & inhibitors<br/>Tirofiban<br/>Tyrosine--analogs & derivatives